Key for crossing the BBB with nanoparticles: the rational design

Scholarly Works

• Shmool, T. A.; Martin, L. K.; Jirkas, A.; Morse, S. V.; Contini, C.; Elani, Y.; Hallett, J. P. Design Principles for Engineering Ionic Liquid-Gold Nanoparticles for Therapeutic Delivery to the Brain. ACS Nano 2025. doi:10.1021/acsnano.5c02375
• Kumbhar, P. S.; Kolekar, K. A.; Vishwas, S.; Kamble, V.; Bashir, B.; Patil, K. S.; Bhagwat, D.; Gupta, G.; Prasher, P.; Singh, M.; Singh, S. K.; Disouza, J.; Patravale, V. B. Plant-based flavonoids and their nanoparticles: Latest arsenal against Alzheimer's disease. Drug Delivery and Translational Research 2025. doi:10.1007/s13346-025-01906-9
• Kumbhar, P. S.; Kolekar, K. A.; Vishwas, S.; Kamble, V.; Bashir, B.; Patil, K. S.; Bhagwat, D.; Gupta, G.; Prasher, P.; Singh, M.; Singh, S. K.; Disouza, J.; Patravale, V. B. Plant-based flavonoids and their nanoparticles: Latest arsenal against Alzheimer's disease. Drug delivery and translational research 2025.
• Parashar, B.; Malviya, R. Industrial Perspective of Minimally Invasive Drug Delivery System. Transdermal Applications of Minimally Invasive Drug Delivery Systems; Springer Nature Singapore, 2025; pp 259–288. doi:10.1007/978-981-96-6275-3_12
• Sanadgol, N.; Abedi, M.; Hashemzaei, M.; Kamran, Z.; Khalseh, R.; Beyer, C.; Voelz, C. Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges. Journal of nanobiotechnology 2025, 23, 453. doi:10.1186/s12951-025-03528-2
• Sharma, P.; Sharma, T.; Bashir, B.; Andotra, N.; Awasthi, A.; Patel, P.; Subramaniyan, V.; Chellappan, D. K.; Gupta, G.; Vishwas, S.; Singh, S. K. Role of Galangin for the Treatment of Alzheimer's Disease: Journey So Far and Road Ahead. Current nutrition reports 2025, 14, 80. doi:10.1007/s13668-025-00669-6
• Ali, S. H.; Ali, H.; Shafi, M.; Malik, A. Breaking barriers: exploring blood-brain barrier crossing mechanisms with nanomedicine for effective glioma treatment. 3 Biotech 2025, 15, 213. doi:10.1007/s13205-025-04378-3
• Tiwari, P.; Prajapati, S.; Dixit, V.; Raza, M. A.; Ajazuddin; Gupta, S. K.; Sharma, M. Recent advancements in nanoparticle drug delivery systems to cure neurological disorders via the nasal route. Neurología Argentina 2025. doi:10.1016/j.neuarg.2025.05.003
• Han, Y.-L.; Li, C.; Yin, H.-H.; He, Y.; Guan, Y.-X. In Silico Screening of Small Molecule Inhibitors for Amyloid-β Aggregation. Journal of chemical information and modeling 2025, 65, 6238–6248. doi:10.1021/acs.jcim.5c00831
• Tarantino, S.; Bianco, A.; De Matteis, V.; Scarpa, E.; Rinaldi, R. Nanotechnology in brain cancer treatment: The role of gold nanoparticles as therapeutic enhancers. Ibrain 2025, 11, 119–145. doi:10.1002/ibra.12198
• Cakir, N.; Altas, B. O.; Kalaycioglu, G. D.; Mustafaoglu, N.; Aydogan, N. Development and characterization of DHA-integrated nanostructured lipid carrier formulations for enhanced cellular binding and uptake. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2025, 720, 137122. doi:10.1016/j.colsurfa.2025.137122
• Wen, Y.; Su, Z.; Zhu, H.; Liu, M.; Li, Z.; Zhang, S.; Cai, S.; Tang, J.; Ding, H.; Zeng, H. Mannitol-facilitated entry of vancomycin into the central nervous system inhibits neuroinflammation in a rat model of MRSA intracranial infection by modulating brain endothelial cells. World journal of emergency medicine 2025, 16, 239. doi:10.5847/wjem.j.1920-8642.2025.057
• Zhou, Y.; Chen, L.; Shang, C.; Hong, Y.; Zhang, H. Targeted Glioma Therapy via TMVP1 Peptide-Modified FLT4 Liposomes: A Novel Molecular Probe Strategy. International journal of nanomedicine 2025, 20, 5231–5246. doi:10.2147/ijn.s517222
• Zhang, Y.; Guo, Z.; Zhang, H.; Wei, H.; Wang, T.; Du, S.; Li, P. Transnasal PLGA Nanoparticles with Terpene Permeation Enhancers: Membrane Remodeling and Tight Junction Modulation for Enhanced Brain Drug Delivery. International journal of molecular sciences 2025, 26, 3861. doi:10.3390/ijms26083861
• Satpathy, B.; Saha, I.; Halder, J.; Rajwar, T. K.; Rai, V. K.; Pradhan, D.; Mishra, A.; Mahanty, R.; Dash, P.; Das, C.; Kar, B.; Ghosh, G.; Rath, G. In vitro and in silico anti-Alzheimer study of rutin embedded with zinc chloride loaded bovine serum albumin nanoparticles. Tissue & cell 2025, 95, 102869. doi:10.1016/j.tice.2025.102869
• Lu, G.; Li, X.; Xu, W.; Zhang, F.; Chen, X.; Wu, H.; Dai, H.; Li, F.; Nie, W. Biocompatible nanozyme with dual catalytic activities for high-performance multimodality therapy against glioblastoma. Biomedical materials (Bristol, England) 2025, 20, 35007. doi:10.1088/1748-605x/adc05b
• Le Meur, M.; Pignatelli, J.; Blasi, P.; Palomo, V. Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders. Advanced drug delivery reviews 2025, 220, 115561. doi:10.1016/j.addr.2025.115561
• Liu, J.; Wang, T.; Dong, J.; Lu, Y. The blood-brain barriers: novel nanocarriers for central nervous system diseases. Journal of nanobiotechnology 2025, 23, 146. doi:10.1186/s12951-025-03247-8
• Razavi, Z. S.; Razavi, F. S.; Alizadeh, S. S. Inorganic nanoparticles and blood-brain barrier modulation: Advancing targeted neurological therapies. European journal of medicinal chemistry 2025, 287, 117357. doi:10.1016/j.ejmech.2025.117357
• Liu, S.; Li, H.; Xi, S.; Zhang, Y.; Sun, T. Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies. International journal of nanomedicine 2025, 20, 1443–1490. doi:10.2147/ijn.s457393

Explore citations to this article at